Atlas Trials

John Quigley

1 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch John Quigley

RecordFirmDate
Study of the Safety and Efficacy of Gemtuzumab Ozogamicin (GO) and Venetoclax in Patients With Relapsed or Refractory CD33+ Acute Myeloid Leukemia:Big Ten Cancer Research Consortium BTCRC-AML17-113 (NCT04070768)John Quigley2019-09-06

Track John Quigley automatically

Every clearance here is in the API, with alerts when new ones post.